Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC
Reihaneh Alsadat Mahmoudian,Sahar Mozhgani,Mohammad Reza Abbaszadegan,Leila Mokhlessi,Mehdi Montazer,Mehran Gholamin
DOI: https://doi.org/10.1007/s10735-021-09971-3
2021-04-21
Journal of Molecular Histology
Abstract:PD-1, PD-L1, CTLA-4, TIM-3, and LAG-3, crucial immune checkpoint molecules in the tumor microenvironment, identify as key targets for cancer immunotherapy. There is a correlation between immune cells and epithelial-mesenchymal transition (EMT)-related genes expression in varies human cancers. In this study, we aimed to investigate the probable association between expression of immune checkpoints and EMT in esophageal squamous cell carcinoma (ESCC) with clinical treats for providing the new therapeutic targets and prognostic value for the disease. Quantitative real-time PCR was used to investigate the gene expression profile of immune checkpoints (<i>PD-1</i>, <i>PD-L1</i>, <i>CTLA-4</i>, <i>TIM-3</i>, and <i>LAG-3</i>) and EMT (<i>TWIST1</i> and <i>MMP-13</i>) genes based on the mRNA expression levels in 51 ESCC tissues. The upregulation of <i>CTLA-4, PD-1, PD-L1, TIM-3</i>, <i>LAG-3</i>, <i>MMP-13</i>, and <i>TWIST1</i> were observed in 31.37%, 29.41%, 21.56%, 39.21%, 25.49%, 60.78%, and 56.86% of ESCC cases at the mRNA level, respectively. Dysregulation of immune checkpoints was related to lymph node involvement, stage of tumor progression, and depth of tumor invasion (<i>P</i> < 0.05). While overexpression of <i>MMP-13</i> and <i>TWIST1</i> was associated with lymph node involvement, stage of tumor progression, and grade of tumor differentiation (<i>P</i> < 0.05). The mRNA expression of immune checkpoint genes was significantly correlated to each other's (<i>P</i> = 0.000). Of importance, the data explored the significant association between the concomitant expression of immune checkpoints and EMT-related genes with each other in a variety of clinicopathological traits (<i>P</i> < 0.05). Consequently, immune checkpoints were positively correlated with EMT status in ESCC. The correlation between tumor immune microenvironment with the elevation of multiple immune checkpoints and EMT status may help to identify potential biomarkers for the simultaneous clinical use of multiple immune checkpoints blockade and other immunotherapies approaches for advanced ESCC patients.
cell biology